This subnnlsslon is in response to CAI 0-503 Comprehensive Partnerships to Reduce Cancer Health Disparities. This application, submitted by the Dana-Farber/Harvard Cancer Center and its partner UMASSBoston, describes plans to transition the successful U56 Partnership to a U54. From its inception, the Partnership has been based on strong institutional support, significant personal commitment of the leadership, and a belief in the institutional benefit that would be derived from a successful partnership. Two key tenets underlie the formation of our Partnership: a) a common and intense interest in addressing the problem of racial, ethnic, and socioeconomic disparities in cancer;and b) a belief that through the partnership, each partner will achieve benefits that neither could achieve on its own. Through careful planning, a mature, solid, and committed partnership has evolved which has been transformative for both institutions. This application provides extensive evidence of the ways these tenets have been operationalized and the resulting benefits, which have been substantial for both institutional partners. In addition to robust Administrative and Planning &Evaluation Cores, and two shared resources (Training Core and Statistical and Survey Methods Core), the application includes rigorous and innovative science, representing basic, clinical, and population science, as well as an innovative post-doctoral training program in nursing and health disparities. The Partnership has strong and enthusiastic personal and institutional support from the leaders of the respective institutions. The Partnership has well-established communication, leadership, and evaluation in place, and Is guided by an outstanding, external Program Steering Committee. This Partnership is fully prepared to move to the U54 mechanism.
This strong and stable Partnership has an excellent track record of developing cancer-focused research activities at the Minority Serving Institution, strengthening the cancer disparities and outreach research programs at the Comprehensive Cancer Center, and conducting robust student training programs. The Partnership is well-positioned to transition to a U54.
|Allen, Jennifer D; Tom, Laura S; Leyva, Bryan et al. (2015) Recruiting and Surveying Catholic Parishes for Cancer Control Initiatives: Lessons Learned From the CRUZA Implementation Study. Health Promot Pract 16:667-76|
|LeBaron, Virginia T; Iribarren, Sarah J; Perri, Seneca et al. (2015) A practical field guide to conducting nursing research in low- and middle-income countries. Nurs Outlook 63:462-73|
|Reid Ponte, Patricia; Hayman, Laura L; Berry, Donna L et al. (2015) A new model for postdoctoral training: the Nursing Postdoctoral Program in Cancer and Health Disparities. Nurs Outlook 63:189-203|
|Latchman, Jessica; Guastella, Ann; Tofthagen, Cindy (2014) 5-Fluorouracil toxicity and dihydropyrimidine dehydrogenase enzyme: implications for practice. Clin J Oncol Nurs 18:581-5|
|Kulkarni, Prajna R; Jia, Tao; Kuehne, Sarah A et al. (2014) A sequence-based approach for prediction of CsrA/RsmA targets in bacteria with experimental validation in Pseudomonas aeruginosa. Nucleic Acids Res 42:6811-25|
|NegrÃ³n, Rosalyn; Leyva, Bryan; Allen, Jennifer et al. (2014) Leadership networks in Catholic parishes: implications for implementation research in health. Soc Sci Med 122:53-62|
|Frenette, Mathieu; Hatamimoslehabadi, Maryam; Bellinger-Buckley, Stephanie et al. (2014) Shining light on the dark side of imaging: excited state absorption enhancement of a bis-styryl BODIPY photoacoustic contrast agent. J Am Chem Soc 136:15853-6|
|Frenette, Mathieu; Hatamimoslehabadi, Maryam; Bellinger-Buckley, Stephanie et al. (2014) Nonlinear optical properties of multipyrrole dyes. Chem Phys Lett 608:303-307|
|Anjum, Saima G; Xu, Wenjian; Nikkholgh, Niusha et al. (2013) Regulation of Toll signaling and inflammation by Î²-arrestin and the SUMO protease Ulp1. Genetics 195:1307-17|
|Veraksa, Alexey (2013) Regulation of developmental processes: insights from mass spectrometry-based proteomics. Wiley Interdiscip Rev Dev Biol 2:723-34|
Showing the most recent 10 out of 20 publications